Allergy Medicine Shot: Why SCIT Is Not a Drug and Why That Matters
An allergy medicine shot could mean SCIT (allergen extract — not a pharmaceutical drug), a biologic injection like Xolair or Dupixent, or a depot corticosteroid like Kenalog. SCIT is the only injection with documented post-treatment remission (Durham 1999 NEJM). The AAAAI/ACAAI rhinitis practice parameter discourages routine depot corticosteroid injections due to adrenal suppression risk. Understanding the category distinction guides the right clinical choice.
6 peer-reviewed sources
Allergy medicine shots include SCIT (allergen extract — the 3-5 year disease-modifying course), biologics like Xolair and Dupixent (disease-treating but not tolerance-inducing), and depot corticosteroids (Kenalog/Depo-Medrol — discouraged for routine use). SCIT is not a conventional drug; it is an allergen extract.
The essentials
Allergy medicine shot is an ambiguous phrase that maps to multiple distinct injectable interventions — and the distinction between them is clinically important. The most effective long-term answer, subcutaneous immunotherapy (SCIT), isn't a 'medicine' in the conventional pharmaceutical sense at all.
SCIT uses allergen extracts — the same proteins patients are allergic to — custom-mixed in the allergist's office from FDA-licensed raw materials supplied by manufacturers like Greer Laboratories, ALK-Abelló, and Hollister-Stier. SCIT extracts are regulated by FDA's Center for Biologics Evaluation and Research (CBER), not the Center for Drug Evaluation and Research (CDER). There is no branded SCIT product — no allergy-shot version of Pfizer or Merck at the pharmacy. The extract is formulated specifically for each patient's sensitization profile per the ACAAI Allergen Immunotherapy Extract Preparation Instructional Guide and the Cox 2011 Practice Parameter Third Update (JACI 2011;127[1 Suppl]:S1-S55).
The injectable products that ARE medicines in the conventional pharmaceutical sense are in three categories. First, the biologics: Xolair (omalizumab, anti-IgE, FDA-approved 2003, with food-allergy expansion February 16, 2024 per the OUtMATCH NEJM 2024 trial); Dupixent (dupilumab, anti-IL-4 receptor alpha, FDA-approved March 2017); and Tezspire (tezepelumab-ekko, anti-TSLP, FDA-approved December 17, 2021). These are subcutaneous injections every 2-4 weeks that treat IgE-mediated or Th2-mediated disease without inducing allergen-specific tolerance — symptoms return on discontinuation. Second, depot corticosteroids: Kenalog-40 (triamcinolone acetonide, first FDA-approved February 1, 1965) and Depo-Medrol (methylprednisolone acetate). These single intramuscular injections suppress allergic symptoms for days to three weeks by broadly dampening the immune system. The AAAAI/ACAAI Joint Task Force Rhinitis Practice Parameter explicitly discourages single parenteral corticosteroid administration for routine allergic rhinitis and states that recurrent administration is contraindicated due to HPA-axis suppression and other systemic glucocorticoid risks.
Before choosing among these options, identifying which allergens actually drive symptoms is essential. Curex's at-home IgE testing with allergist review identifies which allergens drive symptoms, which determines whether immunotherapy (SCIT or sublingual drops) makes sense versus pharmacologic options like antihistamines or biologic injections.
How allergy shots retrain your immune system
SCIT works by leveraging an immune mechanism that no pharmaceutical drug can replicate: allergen-specific tolerance induction via regulatory T cells. Unlike biologics that block upstream cytokines (Dupixent blocks IL-4/IL-13 signaling) or IgE (Xolair captures free IgE before it reaches mast cells), SCIT changes what the immune system does when it encounters the allergen — from launching an inflammatory cascade to generating a tolerogenic response. This mechanism change is why SCIT produces durable post-treatment remission while biologics and corticosteroids do not.
Custom allergen extract preparation
From FDA-licensed raw material (19 standardized extracts per FDA CBER list), the allergist prepares a custom multi-vial mixture matched to the patient's confirmed IgE sensitization profile. No brand name, no pharmacy — this is prepared in the allergy office.
Escalating subcutaneous injections over 4-6 months
Starting at sub-threshold doses, weekly injections introduce allergen proteins that begin shifting immune responses from Th2 to Treg. A mandatory 30-minute post-injection observation period applies at every visit per Cox 2011 PP3.
3-5 year maintenance phase with consolidating immunity
Every 2-4 week maintenance injections consolidate blocking IgG4 antibodies and regulatory T-cell populations. Benefits accumulate progressively and persist after the course ends via long-lived IgG4-producing plasma cells.
Ready to skip the surprise bills?
See if at-home allergy shots fit your allergies — a 2-minute quiz, designed by board-certified allergists, with flat monthly pricing and no clinic visits.
- 4.8/5Patient rating
- $129/moFlat pricing
- 50K+Patients treated
- HSA/FSAEligible
Same proven results. No clinic visits.
Curex's at-home allergy shots deliver the same allergen desensitization as clinic SCIT — for a flat $129/month, with no clinic visits and no facility fees.
See if at-home shots are right for youTreatment options side by side
The four injectable allergy interventions serve fundamentally different clinical purposes, and choosing among them depends on the patient's underlying condition, severity, and treatment goals.
| Treatment | Efficacy | Duration | Cost (5yr) | Convenience | Safety |
|---|---|---|---|---|---|
SCIT (allergen extract — not a drug) | |||||
Xolair (omalizumab) / Dupixent (dupilumab) / Tezspire | |||||
Kenalog-40 / Depo-Medrol (depot corticosteroids) | |||||
At-home allergy shots (Curex SCIT) |
- Efficacy
- Duration
- Cost (5yr)
- Convenience
- Safety
- Efficacy
- Duration
- Cost (5yr)
- Convenience
- Safety
- Efficacy
- Duration
- Cost (5yr)
- Convenience
- Safety
- Efficacy
- Duration
- Cost (5yr)
- Convenience
- Safety
Curex delivers real SCIT allergy shots at home for $129/month — the same allergen-extract immunotherapy as clinic SCIT, with a serum sterile-compounded to USP <797> standards, a prescribed epinephrine auto-injector confirmed on hand, and the first dose plus every dose change supervised live over Zoom by the prescribing allergist. No facility fees, no weekly office trips.
See if at-home shots are right for youFrequently asked questions
Is SCIT considered a medication or a biologic?
SCIT is regulated by the FDA's Center for Biologics Evaluation and Research (CBER) rather than the Center for Drug Evaluation and Research (CDER). Technically, allergen extracts are classified as biologics in the FDA regulatory framework, but they are a distinct category from the monoclonal antibody biologics like Xolair or Dupixent. There is no branded finished-drug SCIT product on the US market — extracts are custom-mixed in each allergist's office from FDA-licensed starting materials provided by manufacturers such as Greer Laboratories, ALK-Abelló, and Hollister-Stier, following the ACAAI mixing guide.
Why are routine allergy steroid shots discouraged?
The AAAAI/ACAAI Joint Task Force Rhinitis Practice Parameter discourages single administration of parenteral corticosteroids (Kenalog-40 or Depo-Medrol) for routine allergic rhinitis and states that recurrent administration is contraindicated. The primary concerns are hypothalamic-pituitary-adrenal axis suppression (a single 80-120 mg methylprednisolone acetate injection suppresses cortisol production for weeks), systemic glucocorticoid side effects with repeated use, and the availability of safer and more effective options — topical nasal corticosteroids, antihistamines, and disease-modifying immunotherapy — that do not carry these systemic risks.
How does Xolair differ from allergy shots as an allergy medicine?
Xolair (omalizumab) is an anti-IgE monoclonal antibody that sequesters free IgE in the bloodstream, reducing the amount available to activate mast cells and basophils. It does not induce allergen-specific tolerance — instead, it reduces the allergic response to any IgE-mediated trigger. Allergy shots (SCIT) are allergen extracts that train the immune system to specifically tolerate defined allergens through regulatory T cells and blocking IgG4 antibodies. SCIT produces durable post-treatment remission; Xolair requires ongoing q2-4 week injections indefinitely, because symptoms return when the drug is discontinued. Xolair is indicated for specific conditions (asthma, CSU, CRSwNP, IgE food allergy) while SCIT is appropriate for aeroallergen sensitization.
What is the difference between a medicine shot and allergy immunotherapy?
The term 'medicine shot' implies a pharmaceutical drug delivered by injection — like Xolair (omalizumab), Dupixent (dupilumab), or depot corticosteroids such as Kenalog and Depo-Medrol. These are conventional drug products regulated by FDA CDER (or the biologics division). Allergy immunotherapy (SCIT) is allergen extract — the same proteins a patient is allergic to, custom-mixed in an allergist's office — regulated by FDA CBER. It is not a medicine in the pharmacy sense but is the only injection-based intervention that produces durable allergen-specific tolerance and post-treatment remission documented in randomized trials.
How is allergy medicine shot different from epinephrine?
Epinephrine (adrenaline) auto-injectors — EpiPen (FDA-approved 1987), Auvi-Q (2012), and the needle-free neffy nasal spray (FDA-approved August 9, 2024) — are emergency rescue medications for anaphylaxis, not treatments for allergic disease. Epinephrine reverses the acute life-threatening manifestations of anaphylaxis within minutes but provides no chronic allergy treatment benefit. Allergy medicine shots in the therapeutic sense (SCIT, biologics) are chronic interventions that require weeks to years for their effects. If you experience throat tightness, difficulty breathing, generalized hives, or lightheadedness after an allergy injection, call 911 immediately and use an epinephrine auto-injector if available.
Are allergy shots available at any doctor's office?
Traditionally, SCIT was administered in a properly equipped medical setting under allergist supervision with epinephrine immediately available, and the initial evaluation, testing, and extract prescription still require allergist expertise. Access is a meaningful barrier — Wu I et al (AAAAI 2019) found only 1.08 board-certified allergists per 100,000 US population, with 82% of US counties having zero allergists. Telehealth plus a personalized serum sterile-compounded to USP <797> standards, a prescribed epinephrine auto-injector confirmed on hand, and a first dose and every dose change supervised live over Zoom now let eligible maintenance patients self-administer the same SCIT at home — the model Curex uses to deliver it for $129/month, widening access well beyond the few counties with an allergist.
Related Articles
Name of Allergy Shots: SCIT, CPT Codes & Brands | Curex
The clinical name for allergy shots is subcutaneous immunotherapy (SCIT), billed as CPT 95117. There is no branded SCIT product — extracts are custom-mixed from Greer, ALK, or HollisterStier.
Read moreShot for Allergy: SCIT Guide & What to Expect | Curex
A shot for allergy means SCIT — a 39-visit Year-1 course, not a single injection. Cochrane 2007: symptom SMD -0.73. Steroid depot shots are professionally discouraged.
Read moreAllergy Shots: The Complete Patient Guide to SCIT | Curex
Allergy shots (SCIT) are the only FDA-recognized disease-modifying allergy treatment. Learn who qualifies, how they work, and what alternatives exist.
Read moreSeasonal Allergy Shot Guide | Curex SCIT Resource
A seasonal allergy shot is SCIT targeting tree, grass, and weed pollens — not a yearly steroid. Cochrane 51 RCTs: symptom SMD −0.73. Learn the full regimen.
Read moreAllergy Immunity Shots: Tolerance, Not Vaccine Immunity
'Allergy immunity shots' = subcutaneous immunotherapy (SCIT). The mechanism is Treg tolerance induction — the opposite of vaccine-style antibody immunity.
Read moreCat Allergy Shots for Humans | Curex SCIT Guide
Cat allergy shots for humans traditionally mean ~95–119 clinic visits over 3–5 years (23.9% quit, Tkacz 2021). Curex delivers that SCIT at home, $129/mo.
Read moreGet your allergy shots — without the clinic.
Curex's flat $129/month covers end-to-end at-home immunotherapy — a personalized serum compounded to USP <797> sterile standards, board-certified allergist oversight, and one weekly injection you give yourself at home. No clinic visits, no facility fees. HSA/FSA eligible.
$129/mo flat · No facility fees · HSA/FSA eligible · Cancel anytime
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.